featured
What Is a Reasonable Time Lapse After a Prior Stroke for Alteplase?
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581-1587.
- Jauch EC, Saver JL, Adams HP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870-947.
- Ringleb A, Bousser M-G, Ford G, et al. Guidelines for management of ischemic stroke and transient ischaemic attack. Cerebrovasc Dis. 2008;25(5):457-507.
- Karlinski M, Kobayashi A, Czlonkowska A, et al. Safe Implementation of Treatments in Stroke-East Registry (SITS-EATS) Investigators. Stroke. 2015;46(11):3184-3189.
- Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet. 2007;369(9558):275-282.
- Mishra NK, Ahmed N, Davalos A, et al. SITS and VISTA collaborators. Thrombolysis outcomes in acute ischemic stroke patients with prior stroke and diabetes mellitus. Neurology. 2011;77(21):1866-1872.
- Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363(9411):768-774.
- Sandercock P, Wardlaw JM, Lindley RI, et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the Third International Stroke Trial [IST-3]): a randomised controlled trial [published correction appears in Lancet. 2012;380:730]. Lancet. 2012;379(9834):2352-2363.